(Q33974663)

30 July 2017

Effects of lowering LDL cholesterol on progression of kidney disease (English)

1 reference

30 July 2017

William G Herrington

14

0 references

Richard Haynes

Richard Haynes

1

0 references

Jonathan Emberson

Jonathan Emberson

3

0 references

Alan Cass

Alan Cass

6

0 references

Bo Feldt-Rasmussen

Bo Feldt-Rasmussen

9

0 references

Jonathan Craig

Jonathan C Craig

7

0 references

Adeera Levin

11

Adeera Levin

1 reference

30 July 2017

4

Christina Reith

1 reference

30 July 2017

5

Lawrence Agodoa

1 reference

30 July 2017

10

Bengt Fellström

1 reference

30 July 2017

David Lewis

2

1 reference

30 July 2017

Dick de Zeeuw

8

1 reference

30 July 2017

David C Wheeler

12

1 reference

30 July 2017

Rob Walker

13

1 reference

30 July 2017

Colin Baigent

15

1 reference

30 July 2017

Martin J Landray

16

1 reference

30 July 2017

SHARP Collaborative Group

17

1 reference

30 July 2017

SHARP Collaborative Group

18

1 reference

30 July 2017

1 May 2014

1 reference

Journal of the American Society of Nephrology

30 July 2017

1 reference

30 July 2017

25

1 reference

30 July 2017

8

1 reference

30 July 2017

1825-1833

1 reference

Chronic kidney disease: global dimension and perspectives

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Longitudinal progression trajectory of GFR among patients with CKD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

5 July 2018

Chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

A new equation to estimate glomerular filtration rate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Statins for improving renal outcomes: a meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Assessing kidney function--measured and estimated glomerular filtration rate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

Clinical epidemiology of cardiovascular disease in chronic renal disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4116066

The quality of life of patients with end-stage renal disease

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24790178

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1681/ASN.2013090965

1 reference

30 July 2017

1 reference

30 July 2017

1 reference